Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Anne Huber und 20 weiteren Autor:innen. Beteiligte Einrichtung: Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tumor Suppressor Protein p53, Interleukin-6, STAT3 Transcription Factor. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, AGAUR, European Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia.
- Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; Department of Gastroenterology, The Alfred Hospital, Melbourne, VIC 3004, Australia.
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain; I…
- Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia; Department of Anatomical Pathology, Austin Health, Heidelberg, VIC 3084, Australia.
- Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia. Electronic address: matthias.ernst@onjcri.org.au.
Förderung
- Medical Research Council
- AGAUR
- European Research Council
- National Health and Medical Research Council
- Debbie's Dream Foundation
- Victorian Cancer Agency
- Olivia Newton-John Cancer Research Institute
- La Trobe University
Zitieren
APA
Huber, A., Allam, A. H., Dijkstra, C., Thiem, S., Huynh, J., Poh, A. R., Konecnik, J., Jacob, S. P., Busuttil, R., Liao, Y., Chisanga, D., Shi, W., Alorro, M. G., Forrow, S., Tauriello, D. V. F., Batlle, E., Boussioutas, A., Williams, D. S., Buchert, M., …, & Eissmann, M. F. (2024). Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114616
Vancouver
Huber A, Allam AH, Dijkstra C, Thiem S, Huynh J, Poh AR, et al. Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114616
BibTeX
@article{Huber2024,
author = {Huber, Anne and Allam, Amr H and Dijkstra, Christine and Thiem, Stefan and Huynh, Jennifer and Poh, Ashleigh R and Konecnik, Joshua and Jacob, Saumya P and Busuttil, Rita and Liao, Yang and Chisanga, David and Shi, Wei and Alorro, Mariah G and Forrow, Stephen and Tauriello, Daniele V F and Batlle, Eduard and Boussioutas, Alex and Williams, David S and Buchert, Michael and Ernst, Matthias and Eissmann, Moritz F},
title = {Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114616}
}
EUVIMED